Varex Imaging (NASDAQ:VREX) Receives Consensus Recommendation of "Reduce" from Brokerages

Key Points

• Analyst consensus is “Reduce”: Seven brokerages covering Varex Imaging include one sell rating and six hold ratings, with an average 12-month price target of $16.875.
• Recent institutional activity was positive: Pzena Investment Management, BlackRock and Rice Hall James initiated sizable positions, while LSV Asset Management increased its stake by 210.7%.
• Quarterly results exceeded expectations on earnings: Varex reported EPS of $0.31 versus the $0.21 consensus estimate, although revenue of $210.5 million fell short of the $215.5 million forecast.

Shares of Varex Imaging (NASDAQ:VREX - Get Free Report) have been assigned a consensus rating of "Reduce" from the seven research firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating and six have assigned a hold rating to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $16.8750.

VREX has been the subject of a number of recent research reports. Zacks Research cut Varex Imaging from a "strong-buy" rating to a "hold" rating in a report on Monday, July 27th. Weiss Ratings upgraded Varex Imaging from a "sell (d-)" rating to a "sell (d+)" rating in a research report on Tuesday, August 11th. B. Riley Financial lowered shares of Varex Imaging from a "buy" rating to a "hold" rating in a research note on Monday, August 10th. Sidoti reiterated a "neutral" rating and set a $19.00 price objective on shares of Varex Imaging in a research report on Monday, August 10th. Finally, Oppenheimer downgraded shares of Varex Imaging from an "outperform" rating to a "market perform" rating in a research note on Monday, August 10th.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Pzena Investment Management LLC purchased a new stake in shares of Varex Imaging in the second quarter worth approximately $45,312,000. BlackRock Inc. purchased a new position in Varex Imaging during the 2nd quarter valued at $40,624,000. Rice Hall James & Associates LLC bought a new position in Varex Imaging in the 2nd quarter valued at $15,080,000. LSV Asset Management increased its stake in Varex Imaging by 210.7% in the fourth quarter. LSV Asset Management now owns 1,244,329 shares of the company's stock worth $14,496,000 after purchasing an additional 843,805 shares during the period. Finally, J. Goldman & Co LP purchased a new stake in Varex Imaging in the second quarter worth $6,215,000.

Varex Imaging Stock Performance

Varex Imaging stock opened at $18.46 on Tuesday. The company's 50-day moving average price is $11.77 and its 200-day moving average price is $11.70. The company has a quick ratio of 1.53, a current ratio of 3.38 and a debt-to-equity ratio of 0.64. The company has a market cap of $777.17 million, a PE ratio of 35.50 and a beta of 0.89. Varex Imaging has a twelve month low of $9.09 and a twelve month high of $18.63.

Varex Imaging (NASDAQ:VREX - Get Free Report) last announced its quarterly earnings results on Monday, August 10th. The company reported $0.31 EPS for the quarter, beating analysts' consensus estimates of $0.21 by $0.10. The firm had revenue of $210.50 million during the quarter, compared to the consensus estimate of $215.50 million. Varex Imaging had a net margin of 2.55% and a return on equity of 9.19%. On average, equities research analysts forecast that Varex Imaging will post 0.93 EPS for the current fiscal year.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company's medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source